Trial intelligence / Profile preview

Testosterone undecanoate in adult men with type 1 diabetes mellitus and hypogonadotropic hypogonadism

2012-000291-42Phase 4Completed

Sponsor
Parc de Salut Mar
Start
Aug 2012
Countries
1
01

Overview

Phase 4, randomised trial in hypogonadotropic hypogonadism (HH) comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoint: Change in estimated glucose disposal rate. Started Aug 2012; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

hypogonadotropic hypogonadism (HH)

Beyond the preview

Go deeper on 2012-000291-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000291-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call